QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.101113v1 318/1/35    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhou, R. Articles by Zuo, J.-P. Search for Related Content PubMed PubMed Citation Articles by Zhou, R. Articles by Zuo, J.-P.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

(5R)-5-Hydroxytriptolide Attenuated Collagen-Induced Arthritis in DBA/1 Mice via Suppressing Interferon- Production and Its Related Signaling

Laboratory of Immunopharmacology (R.Z., W.T., Y.-X.R., P.-L.H., L.-P.S., Y.-F.F., Y.-F.Y., J.-P.Z.) and Laboratory of Chemistry (F.Z., Y.-C.L.), State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China; and Department of Oncology (S.O., H.F.), Osaka University Graduate School of Medicine, Osaka, Japan

(5R)-5-Hydroxytriptolide (LLDT-8) displays strong immunosuppressive activities both in vitro and in vivo in our previous studies. This study aims to investigate whether LLDT-8 has antiarthritic potential in a murine model of type II bovine collagen (CII)-induced arthritis (CIA) and to show the mechanism(s) of LLDT-8 action. DBA/1 mice were immunized with CII to induce arthritis and administered with LLDT-8. The severity of arthritis was evaluated according to the clinical score and joint damage. The effects of LLDT-8 on immune responses were determined by measurement of serum antibody levels, lymphocyte proliferation assay, cytokine assay, nitric oxide (NO) production, arginase activity assays, fluorescence-activated cell sorting analysis of splenic Mac-1⁺ cells, as well as polymerase chain reaction analysis for interferon- (IFN-)-related gene expression. We showed that LLDT-8 treatment significantly reduced the incidence and severity of CIA. The preventive and therapeutic effects of LLDT-8 are associated with 1) reduction of serum anti-CII immunoglobulin (Ig) G, IgG2a, and IgG1 levels; 2) inhibition of CII-specific lymphocyte proliferation, IFN- and interleukin-2 production; 3) blockade of gene expressions in IFN- signaling, including IFN- production pathways [signal transducer and activator of transcription (STAT) 1, T-box transcription factor, interleukin 12R2, and STAT4] and IFN--induced chemokine transcription [macrophage inflammatory protein (Mip)-1, Mip-1, regulated on activation normally T cell expressed and secreted, and inducible protein 10]; and 4) retardation of the abnormal increase of NO via IFN-/STAT1/interferon regulatory factor 1/inducible nitric-oxide synthase pathway and arginase activity. Moreover, the mRNA transcription of chemokine receptors was also suppressed [including C-C chemokine receptor (CCR) 1, CCR5, and C-X-C chemokine receptor 3]. In conclusion, our data suggest that the antiarthritic effect of LLDT-8 is closely related to the blockade of IFN- signaling. LLDT-8 may have a therapeutic value in the treatment of rheumatoid arthritis.

Address correspondence to: Dr. Jian-Ping Zuo, Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, People's Republic of China. E-mail: jpzuo{at}mail.shcnc.ac.cn